All Discovery Content

Bringing you the latest research in Drug Discovery In New Modalities, Integration Of DEL, Covalent Inhibitors, Protein Degradation Technologies, Computational Drug Design & Automation Strategies and more, through a range of Speaker Interviews, Industry Insights, and Expert Opinions.
Whitepaper
Causaly have developed an advanced machine-reading platform for semantic relationship extraction and comprehension
09 June 2022
Computational Drug Design & AI
Whitepaper
The fastest way to find evidence, explore hidden connections, and make new predictions
09 June 2022
Computational Drug Design & AI
Discussion Group Report
Govinda Bhisetti, Principal Investigator and Head of Computational Chemistry at Biogen, leads a discussion group on what the revolutionary machine learning technology means for drug design.
Edited by Tom Cohen |
21 April 2022
Computational Drug Design & AI
Commentary
There are innumerable possible compounds in Merck KGaA’s virtual library, so finding drug candidates is only possible with the help of computational methods.
Edited by Tom Cohen |
23 March 2022
Computational Drug Design & AI
Insight Article
Artificial intelligence and machine learning could be an invention comparable to electricity, so what does the future hold for its use in drug discovery?
Edited by Tom Cohen |
16 March 2022
Computational Drug Design & AI
Whitepaper
In drug discovery, structural knowledge of a target enables structure-based design approaches and thereby reduces the time and labor required to develop a therapy.
15 November 2021
Computational Drug Design & AI
Whitepaper
A platform company service provider in small molecule preclinical space
15 November 2021
Computational Drug Design & AI
Whitepaper
Any AI tool can provide suggestions, Reaxys offers solutions
13 November 2021
Computational Drug Design & AI
Whitepaper
Reaxys prediction retrosynthesis predicts the synthesis route for BMS-986299 targeting NLRP3 inflamasone, a protein that can stimulate the immune system’s ability to recognize and fight tumor cells
13 November 2021
Computational Drug Design & AI
Whitepaper
A global drug-discovery team at Novartis is working to address current and future pandemics with help from Nanome and Oculus.
13 November 2021
Computational Drug Design & AI

Search by Keyword

Filter by Subject Area

Filter by Content Type

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login